[{"orgOrder":0,"company":"Wanbury Limited","sponsor":"Cipla","pharmaFlowCategory":"D","therapeuticArea":"Hematology","country":"INDIA","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2020","type":"Acquisition","leadProduct":"Folic Acid","moa":"||Folate receptor (FOLR)","graph1":"Hematology","graph2":"Approved FDF","graph3":"Wanbury Limited","amount2":0.01,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Hematology","amount2New":0.01,"dosageForm":"Oral Tablet","sponsorNew":"Wanbury Limited \/ Cipla","highestDevelopmentStatusID":"15","companyTruncated":"Wanbury Limited \/ Cipla"},{"orgOrder":0,"company":"BIOSYENT PHARMA INC","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"CANADA","productType":"Other Small Molecule","year":"2023","type":"Inapplicable","leadProduct":"Inositol","moa":"||HCAR3\/NIACR1","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Approved FDF","graph3":"BIOSYENT PHARMA INC","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Oral Capsule","sponsorNew":"BIOSYENT PHARMA INC \/ Inapplicable","highestDevelopmentStatusID":"15","companyTruncated":"BIOSYENT PHARMA INC \/ Inapplicable"}]

Find Clinical Drug Pipeline Developments & Deals for Folvite

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Peptide Process CMC
                          Not Confirmed
                          Peptide Process CMC
                          Not Confirmed

                          Details : Inofolic is a natural health product, combining myo-inositol and folic acid in a unique soft-gel capsule for women living with PCOS. Inofolic® helped 70% of women with PCOSii to regulate their menstrual cycles throughout the 16-week study period.

                          Product Name : Inofolic

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          August 08, 2023

                          Lead Product(s) : Inositol,Folic Acid

                          Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

                          Highest Development Status : Approved FDF

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          Peptide Process CMC
                          Not Confirmed
                          Peptide Process CMC
                          Not Confirmed

                          Details : Cipla has acquired the four brands namely CPink, CDense, Productiv and Folinine to further strengthen its presence in the women's health segment, Cipla said in a filing to the BSE.

                          Product Name : Undisclosed

                          Product Type : Vitamins/Minerals/Inorganic Salts

                          Upfront Cash : Undisclosed

                          July 02, 2020

                          Lead Product(s) : Folic Acid,Iron

                          Therapeutic Area : Hematology

                          Highest Development Status : Approved FDF

                          Sponsor : Cipla

                          Deal Size : $12.3 million

                          Deal Type : Acquisition

                          blank

                          03

                          Shenzhen Ausa Pharmed Co.,Ltd

                          Country arrow
                          Peptide Process CMC
                          Not Confirmed

                          Shenzhen Ausa Pharmed Co.,Ltd

                          Country arrow
                          Peptide Process CMC
                          Not Confirmed

                          Lead Product(s) : Folic Acid

                          Therapeutic Area : Cardiology/Vascular Diseases

                          Study Phase : Phase IV

                          Sponsor : Second Affiliated Hospital, Nanchang University | Shenzhen Evergreen Medical Institute | Nanfang Hospital, Southern Medical University | Peking University First Hospital | The First People's Hospital of Lianyungang | People's Hospital of Rongcheng | Anqin

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Vitamins/Minerals/Inorganic Salts

                          Upfront Cash : Inapplicable

                          March 21, 2018

                          Lead Product(s) : Folic Acid

                          Therapeutic Area : Cardiology/Vascular Diseases

                          Highest Development Status : Phase IV

                          Sponsor : Second Affiliated Hospital, Nanchang University | Shenzhen Evergreen Medical Institute | Nanfang Hospital, Southern Medical University | Peking University First Hospital | The First People's Hospital of Lianyungang | People's Hospital of Rongcheng | Anqin

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          McLean Hospital

                          Country arrow
                          Peptide Process CMC
                          Not Confirmed

                          McLean Hospital

                          Country arrow
                          Peptide Process CMC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          April 14, 2017

                          Lead Product(s) : Folic Acid

                          Therapeutic Area : Psychiatry/Psychology

                          Highest Development Status : Undisclosed

                          Sponsor : Genomind

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          The Hospital for Sick Children

                          Country arrow
                          Peptide Process CMC
                          Not Confirmed

                          The Hospital for Sick Children

                          Country arrow
                          Peptide Process CMC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : PregVit

                          Product Type : Vitamins/Minerals/Inorganic Salts

                          Upfront Cash : Inapplicable

                          November 25, 2014

                          Lead Product(s) : Folic Acid

                          Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

                          Highest Development Status : Phase IV

                          Sponsor : Duchesnay

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          The Hospital for Sick Children

                          Country arrow
                          Peptide Process CMC
                          Not Confirmed

                          The Hospital for Sick Children

                          Country arrow
                          Peptide Process CMC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : PregVit

                          Product Type : Vitamins/Minerals/Inorganic Salts

                          Upfront Cash : Inapplicable

                          November 24, 2014

                          Lead Product(s) : Folic Acid

                          Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

                          Highest Development Status : Phase IV

                          Sponsor : Duchesnay

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          07

                          Zhao gengli

                          Country arrow
                          Peptide Process CMC
                          Not Confirmed

                          Zhao gengli

                          Country arrow
                          Peptide Process CMC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Vitamins/Minerals/Inorganic Salts

                          Upfront Cash : Inapplicable

                          August 20, 2014

                          Lead Product(s) : Folic Acid

                          Therapeutic Area : Hematology

                          Highest Development Status : Undisclosed

                          Sponsor : CSL Vifor

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          08

                          PD Dr. med. Volker Heinemann

                          Country arrow
                          Peptide Process CMC
                          Not Confirmed

                          PD Dr. med. Volker Heinemann

                          Country arrow
                          Peptide Process CMC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Vitamins/Minerals/Inorganic Salts

                          Upfront Cash : Inapplicable

                          June 29, 2011

                          Lead Product(s) : Folic Acid

                          Therapeutic Area : Oncology

                          Highest Development Status : Phase II

                          Sponsor : Amgen Inc

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank